Acute effects of capsaicin on proopiomelanocortin mRNA levels in the arcuate nucleus of Sprague-Dawley rats

Psychiatry Investigation

Volumn 9, Issue 2, 2012, Pages 187-190

  Lee, Jin Seong ^a   Kim, Sung Gon ^b   Kim, Hyeun Kyeung ^c   Baek, Sun Yong ^b   Kim, Cheol Min ^b  

^a Pusan National University Yangsan Hospital   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

endorphin; Capsaicin; Proopioimelanocortin (POMC); Sprague dawley rats

Indexed keywords

CAPSAICIN; MESSENGER RNA; OPIATE RECEPTOR; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOTHALAMUS; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

EID: 84863455149     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2012.9.2.187     Document Type: Article

References (23)

1. Wise RA. Brain reward circuitry: insights from unsensed incentives. Neuron 2002;36:229-240.
2. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987;94:469-492.
3. Manzanares J, Durham RA, Lookingland KJ, Moore KE. delta-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat. Eur J Pharmacol 1993;249:107-112.
4. Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 1992;89:2046-2050.
5. Oswald LM, Wand GS. Opioids and alcoholism. Physiol Behav 2004;81: 339-358.
6. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991;43:143-201.
7. Szolcsanyi J, Jancso-Gabor A, Joo F. Functional and fine structural characteristics of the sensory neuron blocking effect of capsaicin. Naunyn Schmiedebergs Arch Pharmacol 1975;287:157-169.
8. Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51:159-212.
9. Robbins W. Clinical applications of capsaicinoids. Clin J Pain 2000;16(2 Suppl):S86-S89.
10. Bach FW, Chaplan SR, Jang J, Yaksh TL. Cerebrospinal fuid beta-endorphin in models of hyperalgesia in the rat. Regul Pept 1995;59:79-86.
11. Gamse R. Capsaicin and nociception in the rat and mouse. Possible role of substance P. Naunyn Schmiedebergs Arch Pharmacol 1982;320:205-216.
12. Koenig JI, Meltzer HY, Gudelsky GA. Morphine or capsaicin administration alters the secretion of beta-endorphin into the hypophysial portal vasculature of the rat. Neuroendocrinology 1986;43:611-617.
13. Mantyh P W, Hunt S P. Hot peppers and pain. Neuron 1998;21:644-645.
14. Bach F W, Yaksh TL. Release of beta-endorphin immunoreactivity into ventriculo-cisternal perfusate by lumbar intrathecal capsaicin in the rat. Brain Res 1995;701:192-200.
15. Rozin P. Acquisition of food preferences and attitudes to food. Int J Obes 1980;4:356-363.
16. Rozin P, Ebert L, Schull J. Some like it hot: a temporal analysis of hedonic responses to chili pepper. Appetite 1982;3:13-22.
17. Rozin P. Getting to Like the Burn of Chili Pepper: Biological and Psychological and Cultural Factors. In: Green BG, Mason JR, Kare MR, Editors. Chemical Irritation in the Nose and Troat. New York: Marcel Dekker; 1990.
18. Stern J, Stern M. Chili Nation. New York: Clarkson Potter; 1999.
19. Garcia de Yebenes E, Pelletier G. Opioid regulation of proopiomelanocortin (POMC) gene expression in the rat brain as studied by in situ hybridization. Neuropeptides 1993;25:91-94.
20. Wu P, Childs G V. Changes in rat pituitary POMC mRNA after exposure to cold or a novel environment, detected by in situ hybridization. J Histochem Cytochem 1991;39:843-852.
21. Panerai AE, Martini A, Locatelli V, Mantegazza P. Capsaicin decreases B-endorphin hypothalamic concentrations in the rat. Pharmacol Res Commun 1983;15:825-832.
22. Kim SG. Effect of capsaicin on alcohol intake in C57BL/6 mice. J Korean Neuropsychiatr Assoc 2004;43:564-569.
23. Niikura K, Narita M, Butelman ER, Kreek MJ, Suzuki T. Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopa-minergic transmission. Trends Pharmacol Sci 2010;31:299-305.